Cystic Fibrosis Clinical Trials in Denver, Colorado

6 studies are recruiting for cystic fibrosis in Denver, Colorado right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Impact of Sinus Surgery on Individuals With Cystic Fibrosis

   This study will be a prospective, observational study of patients who undergo endoscopic sinus surgery for cystic fibrosis-related chronic rhinosinusitis (CRS). Individuals who do not undergo surgery but are treated medically for CRS will also be enrolled to serve as a control group. Outcomes analy…

   Stage

   Not phased

   Ages

   18 to 99

   Site

   National Jewish Health, Denver, Colorado

   Locations

   9 in total

   Run by

   University of California, Los Angeles

   See if you can join NCT04469439 on ClinicalTrials.gov

2. Remote Sputum Collection in Cystic Fibrosis

   Elexacaftor/Tezacaftor/Ivacaftor or Trikafta improves lung health in people with cystic fibrosis (CF), including decreased cough and mucous production. Diagnosing lung infections has become more challenging due to the decrease in sputum and rise of telehealth services. While the option of collectin…

   Stage

   Not phased

   Ages

   18 and older

   Site

   National Jewish Health, Denver, Colorado

   Locations

   4 in total

   Run by

   University of Pennsylvania

   See if you can join NCT06950892 on ClinicalTrials.gov

3. Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis

   The goal of this clinical trial is to learn if drug SPL84 is safe for adult patients with cystic fibrosis (CF). It will also learn if the drug works to treat works to treat CF with a specific mutation (3849 +10kb C-->T). The purpose of this research study is to test the safety and effectiveness of …

   Stage

   Phase 2

   Ages

   18 and older

   Site

   National Jewish Health, Denver, Colorado

   Locations

   3 in total

   Run by

   SpliSense Ltd.

   See if you can join NCT06429176 on ClinicalTrials.gov

4. Health Outcomes of Parents With Cystic Fibrosis-Aim 2

   The goal of this observational prospective study is to determine the health impact of parenthood on United States (US) people with CF in the era of CF transmembrane regulator protein (CFTR) modulators. The investigators will collect physical and mental health data to comprehensively evaluate the im…

   Stage

   Not phased

   Ages

   18 and older

   Site

   National Jewish Health, Denver, Colorado

   Locations

   18 in total

   Run by

   University of Pittsburgh

   See if you can join NCT06296394 on ClinicalTrials.gov

5. Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)

   RETRIAL is a multi-site observational study of people with Cystic Fibrosis (PWCF) ages 6 and up starting the new triple-therapy modulator (vanzacaftor/tezacaftor/deutivacaftor (VTD)), after having experienced neuropsychiatric events and/or liver injury while taking elexacaftor/tezacaftor/ivacaftor …

   Stage

   Not phased

   Ages

   6 and older

   Site

   National Jewish Health, Denver, Colorado

   Locations

   18 in total

   Run by

   Boston Children's Hospital

   See if you can join NCT06683092 on ClinicalTrials.gov

6. A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

   The REACH study is for people with CF who do not take cystic fibrosis transmembrane conductance regulator (CFTR) modulators. The goal of the REACH study is to collect research data, including health data and specimens, from people with CF who do not take CFTR modulators. This data may be used to in…

   Stage

   Not phased

   Ages

   12 and older

   Site

   National Jewish Health, Denver, Colorado

   Locations

   68 in total

   Run by

   Nicole Hamblett

   See if you can join NCT06504589 on ClinicalTrials.gov